The tissues and biologics business will retain the RTI Surgical name, according to a Jan. 4 news release. Olivier Visa, CEO, will continue leading the Alachua, Fla.-based brand. It will focus on allograft and xenograft tissue-based implants.
The metals business, which focuses on implants and instruments for spine, orthopedic and cardiothoracic applications will be called Resolve Surgical Technologies. Megan Osorio, the current president of the metals business, will lead the company.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
